Purification of protein phosphatase 4 catalytic subunit: Inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters

FEBS Letters

Volumn 431, Issue 3, 1998, Pages 357-361

  Hastie, C James ^a   Cohen, Patricia T W ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Centrosome; Chromosome 16; Fostriecin; Microtubule; Protein phosphatase; Tumor promoter

Indexed keywords

ANTINEOPLASTIC AGENT; CALYCULIN A; CANTHARIDIN; CYANOGINOSIN LR; FOSTRIECIN; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN PHOSPHATASE 4; TAUTOMYCIN; TOXIN; TUMOR PROMOTER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CENTROSOME; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PURIFICATION; GEL FILTRATION; GENE MAPPING; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; SWINE; TESTIS;

ALKENES; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTICARCINOGENIC AGENTS; CARCINOGENS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 16; ENZYME INHIBITORS; HUMANS; HYBRID CELLS; MALE; PHOSPHOPROTEIN PHOSPHATASE; PYRONES; RABBITS; SWINE; TESTIS;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 0032563347     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)00775-3     Document Type: Article

References (38)

1. da Cruz e Silva, O.B., da Cruz e Silva, E.F. and Cohen, P.T.W. (1988) FEBS Lett. 242, 106-110.
2. Cohen, P.T.W. (1997) Trends Biochem. Sci. 22, 245-251.
3. Hemmings, B.A., Adams-Pearson, C., Maurer, F., Müller, P., Goris, J., Merlevede, W., Hofsteenge, J. and Stone, S.R. (1990) Biochemistry 29, 3166-3173.
4. Brewis, N.D., Street, A.J., Prescott, A.R. and Cohen, P.T.W. (1993) EMBO J. 12, 987-996.
5. Helps, N.R., Brewis, N.D., Lineruth, K., Davis, T., Kaiser, K. and Cohen, P.T.W. (1998) J. Cell Sci. 111, 1331-1340.
6. Snaith, H.A., Armstrong, C.A., Guo, Y., Kaiser, K. and Cohen, P.T.W. (1996) J. Cell Sci. 109, 3001-3012.
7. Tournebize, R., Andersen, S.S.L., Verde, F., Dorée, M., Karsenti, E. and Hyman, A.A. (1997) EMBO J. 16, 5537-5549.
8. Stampwala, S.S., Bunge, R.H., Hurley, T.R., Willmer, N.E. and Branckiewicz, A.J. (1983) J. Antibiot. Tokyo 36, 1601-1605.
9. Tunac, J.B., Graham, B.D. and Dobson, W.E. (1983) J. Antibiot. Tokyo 36, 1595-1600.
10. Scheithauer, W., Von-Hoff, D.D., Clark, G.M., Shillis, J.L. and Elslager, E.F. (1986) Eur. J. Cancer Clin. Oncol. 22, 921-926.
11. Leopold, W.R., Shillis, J.L., Mertus, A.E., Nelson, J.M., Roberts, B.J. and Jackson, R.C. (1984) Cancer Res. 44, 1928-1932.
12. de Jong, R.S., de Vries, E.G. and Mulder, N.H. (1997) Anticancer Drugs 8, 413-418.
13. Boritzki, T.J., Wolfard, T.S., Besserer, J.A., Jackson, R.C. and Fry, D.W. (1988) Biochem. Pharmacol. 37, 4063-4068.
14. Guo, X.W., Th'ng, J.P.H., Swank, R.A., Anderson, H.J., Tudan, C., Bradbury, E.M. and Roberge, M. (1995) EMBO J. 14, 976-985.
15. Roberge, M., Tudan, C., Hung, S.M., Harder, K.W., Jirik, F.W. and Anderson, H. (1994) Cancer Res. 54, 6115-6121.
16. Ho, D.T. and Roberge, M. (1996) Carcinogenesis 17, 967-972.
17. Walsh, A.H., Cheng, A. and Honkanen, R.E. (1997) FEBS Lett. 416, 230-234.
18. Cohen, P., Alemany, S., Hemmings, B.A., Resink, T.J., Stralfors, P. and Tung, H.Y.L. (1988) Methods Enzymol. 159, 390-408.
19. Barker, H.M., Craig, S.P., Spurr, N.K. and Cohen, P.T.W. (1993) Biochim. Biophys. Acta 1178, 228-233.
20. Alessi, D.R., Street, A.J., Cohen, P. and Cohen, P.T.W. (1993) Eur. J. Biochem. 213, 1055-1066.
21. Blum, H., Beier, H. and Gross, H.J. (1987) Electrophoresis 8, 93-99.
22. McGowan, C.H. and Cohen, P. (1988) Methods Enzymol. 159, 416-426.
23. Barker, H.M., Jones, T.A., da Cruz e Silva, E.F., Spurr, N.K., Sheer, D. and Cohen, P.T.W. (1990) Genomics 7, 159-166.
24. Jones, T.A., Barker, H.M., da Cruz e Silva, E.F., Mayer-Jaekel, R.E., Hemmings, B.A., Spurr, N.K., Sheer, D. and Cohen, P.T.W. (1993) Cytogenet. Cell Genet. 63, 35-41.
25. Brewis, N.D. and Cohen, P.T.W. (1992) Biochim. Biophys. Acta 1171, 231-233.
26. Larin, Z., Monaco, A.P. and Lehrach, H. (1991) Proc. Natl. Acad. Sci. USA 88, 4123-4127.
27. Bentley, D.R., Todd, C., Collins, J., Holland, J., Dunham, I., Hassock, S., Bankier, H.A. and Giannelli, F. (1992) Genomics 12, 534-541.
28. Brewis, N.D.(1992) Ph.D. Thesis, University of Dundee, Dundee.
29. Huang, X., Cheng, A. and Honkanen, R.E. (1997) Genomics 44, 336-343.
30. Aapro, M. (1996) Anticancer Drugs 7, 33-36.
31. MacKintosh, C. and MacKintosh, R.W. (1994) Trends Biochem. Sci. 19, 444-447.
32. Cohen, P., Holmes, C.F. and Tsukitani, Y. (1990) Trends Biochem. Sci. 15, 98-102.
33. Kloeker, S., Bryant, J.C., Strack, S., Colbran, R.J. and Wadzinski, B.E. (1997) Biochem. J. 327, 481-486.
34. Lee, J. and Stock, J. (1993) J. Biol. Chem. 268, 19192-19195.
35. Turowski, P., Fernandez, A., Favre, B., Lamb, N.J.C. and Hemmings, B.A. (1995) J. Cell Biol. 129, 397-410.
36. Bastians, H., Krebber, H., Hoheisel, J., Ohl, S., Lichter, P., Ponstingl, H. and Joos, S. (1997) Genomics 42, 181-182.
37. Panagopoulos, I., Mandahl, N., Mitelman, F. and Aman, P. (1995) Oncogene 11, 1133-1137.
38. Mitelman, F. (1994) in: Catalogue of Chromosome Aberrations in Cancer, 5th edn., pp. 2620-2747, Wiley-Liss, New York.